Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Global Summit
General Topic: Education and Workforce

10F103: Actions with Impact: Health Policy and Global Rheumatology

Friday, November 10, 2023
10:45 AM – 11:45 AM PT
CE: 1

On Demand Livestreamed

    Virtual Moderator(s)

  • JE

    Joad Eseddi, MD

    UT Southwestern Medical Center
    Dallas, TX, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • Laura Lewandowski, MD, MSc

    NIAMS, NIH
    Bethesda, MD, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

    • Virtual Speaker(s)

  • CE

    Cuoghi Edens, MD, FAAP

    University of Chicago
    Chicago, IL, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • JM

    Jane Munro, MD

    Royal Children's Hospital
    Parkville, Victoria, Australia

    Disclosure(s): Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 9, 2023)

  • WS

    Waheba Slamang, MD

    University of Cape Town, Department of Child and Adolescent Health
    Cape Town, South Africa

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • MZ

    Maria del Carmen Zamora Medina, MD

    National Institute of Perinatology
    Mexico City, Federal District, Mexico

    Disclosure(s): Exeltis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Werfen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Health policy is central to access to rheumatology clinical care, education and training, and research. This session will highlight the impact health policy can have on patient care. Through the presentations, this session will demonstrate different ways the policy can act as a barrier or facilitator to optimal care, including the impact of laws on reproductive rights, the power of advocacy to improve health care access at a national level, and the international impact of improving the WHO Essential Medicines list to include more appropriate medication to treat rheumatic diseases in children.

Learning Objectives:

  • Upon completion, participants will be able to describe real-world examples of the importance of health policy in providing access to effective and equitable rheumatology care.
  • Upon completion, participants will be able to identify opportunities to participate in advocacy programs focused on rheumatology.
  • Upon completion, participants will be able to recognize the potential use of health policy to build local research capacity.

Presentations:

  • 10:45 AM – 10:50 AM PT
    Actions with Impact: Health Policy and Global Rheumatology - Introductions

    Virtual Moderator: Joad Eseddi, MD – UT Southwestern Medical Center

    Virtual Moderator: Laura B. Lewandowski, MD, MSc – NIAMS, NIH

  • 10:50 AM – 11:00 AM PT
    Reproductive Rights and Rheumatology: Mexico and the United States - Part 1

    Virtual Speaker: Cuoghi Edens, MD, FAAP – University of Chicago

  • 11:00 AM – 11:10 AM PT
    Reproductive Rights and Rheumatology: Mexico and the United States - Part 2

    Virtual Speaker: Maria del Carmen Zamora Medina, MD – National Institute of Perinatology

  • 11:00 AM – 11:15 AM PT
    Q&A
  • 11:15 AM – 11:25 AM PT
    Advocacy in Action: Rheumatology Access in Australia

    Virtual Speaker: Jane Munro, MD – Royal Children's Hospital

  • 11:25 AM – 11:30 AM PT
    Q&A
  • 11:30 AM – 11:40 AM PT
    Strengthening Health Systems for Musculoskeletal Health in Low- and Middle-Income Countries

    Virtual Speaker: Waheba Slamang, MD – University of Cape Town, Department of Child and Adolescent Health

  • 11:40 AM – 11:45 AM PT
    Q&A